banning semaglutide A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Hair loss with GLP-1 drugs

Semaglutide has been associated with early worsening of diabetic retinopathy in clinical trials, particularly in patients with pre-existing retinopathy and rapid improvement in glycaemic control

Realistic skin improvements begin appearing around week 4-6 as the first collagen remodeling cycle completes and continues improving through week 12 and beyond

The combination creates enhanced healing effects beyond what either approach achieves alone

31 Previous clinical trials (including two Phase 1 and one Phase 2a study) could demonstrate that continuous subcutaneous ND0612 delivery yielded steady-state plasma concentrations estimated to be in a therapeutic window

The specific dose depends on your baseline B12 level, dietary sources, and how long you plan to continue semaglutide therapy